Fundacion Centro Nacional DE Investigaciones Oncologicas Carlos III, Cnio
USPTO PatentsView assignee record - 6 granted patents across 5 technology areas, recorded in grant years 2015–2022. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations).
The verdict
According to USPTO PatentsView, Fundacion ranks #40,325 of 49,997 tracked US assignees by granted-patent volume, with 6 patents across 5 technology areas.
- #40,325
- of 49,997 US assignees by volume
- 26th percentile
- by Innovation Score (28.0/100)
- 11.2
- avg claims per patent
- -80%
- grant velocity, last 5 yrs
USPTO PatentsView assignee plate
Corpus R40325 · Foreign Corporation #40,325 · 6 grants
GRANTS-MICRO · LOWER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-PAR · TYPE-FRNCORP · VEL-DROP · BOOK-FULL
- GRANTS-MICRO 6 grants
- LOWER-Q #40,325/49,997
- PHOTO-FINISH Fulcrum Global
- CPC-NARROW A61P · 5 areas
- INNOV-THIN 28.0/100
- CLAIMS-PAR 11.2 claims/avg
- TYPE-FRNCORP Foreign Corp
- VEL-DROP -80% vel
- BOOK-FULL 10/10 fields
Nearest grant-volume peer: Fulcrum Global Technologies Inc. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Fundacion’s 28.0 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Fundacion
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- Fundacion Centro… · this assignee 28
Fundacion Centro… · this assignee
28 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Fundacion's Innovation Score is 28.0/100 (26th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Fundacion?
Each dot is one of Fundacion’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Fundacion’s own 11.2 claims/patent is at or below the 13.7 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.
Where Fundacion's grants concentrate
Fundacion Centro Nacional DE Investigaciones Oncologicas Carlos III, Cnio is a focused PatentsView assignee: 5 CPC subclasses with 83.3% of grants classified under A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations). Peak complete grant year is 2016 (2 grants) versus a trough of 1 in 2015. By volume, Fundacion sits between Fulcrum Global Technologies Inc. and Fung Lead Medical AND Sports Co., Ltd..
Fundacion's three-year grant acceleration
Fundacion Centro Nacional DE Investigaciones Oncologicas Carlos III, Cnio shows 1 grants in 2022–2024 against only 0 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.
Who files at Fundacion's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Fulcrum Global
Fulcrum Global Technologies Inc.
6 patents
- Fullhope Biomedic…
Fullhope Biomedical Co., Ltd.
6 patents
- Fulterer & KG
Fulterer AG & Co KG
6 patents
- Fuma International
Fuma International, LLC
6 patents
- FundaciÓN Centro…
FUNDACIÓN Centro DE INVESTIGACIÓN Cooperativa DE ENERGÍAS Alternativas CIC Energigune Fundazioa
6 patents
- FundaciÓN PÚBlica…
FUNDACIÓN PÚBLICA Andaluza Progreso Y Salud
6 patents
- FundaÇÃO Universi…
FUNDAÇÃO Universidade DE BRASÍLIA
6 patents
- Fung Lead Medical…
Fung Lead Medical AND Sports Co., Ltd.
6 patents
- Fundacion Centro… ◀
Fundacion Centro Nacional DE Investigaciones Oncologicas Carlos III, Cnio
6 patents
What this shows Fundacion holds 6 patents at rank #40,238, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Fundacion
By rank, the assignees closest to #40,238 in granted patent volume.
- Fulcrum Global Technologies Inc. #40,234 · 6 patents
- Fullhope Biomedical Co., Ltd. #40,235 · 6 patents
- Fulterer AG & Co KG #40,236 · 6 patents
- Fuma International, LLC #40,237 · 6 patents
- FUNDACIÓN Centro DE INVESTIGACIÓN Cooperativa DE ENERGÍAS Alternativas CIC Energigune Fundazioa #40,239 · 6 patents
- FUNDACIÓN PÚBLICA Andaluza Progreso Y Salud #40,240 · 6 patents
- FUNDAÇÃO Universidade DE BRASÍLIA #40,241 · 6 patents
- Fung Lead Medical AND Sports Co., Ltd. #40,242 · 6 patents
Leaders in A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…)
Other assignees with the most granted patents in Fundacion's primary technology class.
- The Regents of the University of California 1,387 in class
- Novartis AG 1,071 in class
- Merck Sharp & Dohme LLC 889 in class
- Bristol-Myers Squibb Company 879 in class
- Genentech, Inc. 789 in class
- The Board of Regents of the University of Texas System 744 in class
- Hoffmann-La Roche Inc. 722 in class
- The United States of America, as represented by the Secretary, Department of Health and Human Services 721 in class
Fundacion's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
28 26th percentile higher than 26% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 1 | 16.7% |
| 2016 | 2 | 33.3% |
| 2017 | 2 | 33.3% |
| 2022 | 1 | 16.7% |
Which technologies does Fundacion Centro Nacional DE Investigaciones Oncologicas Carlos III, Cnio patent most?
Top 5 of 5 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
Fundacion Centro Nacional DE Investigaciones Oncologicas Carlos III, Cnio's patent record in context - here's where to go next.
- Fundacion Centro Nacional DE Investigaciones Oncologicas Carlos III, Cnio's lead technology class is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations), 83.3% of its portfolio - see every assignee active in that class. Explore A61P
- Ranked #40,325 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare Fundacion Centro Nacional DE Investigaciones Oncologicas Carlos III, Cnio against Fulcrum Global Technologies Inc., an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 28.0/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.